Artificial DNA producer Twist Bioscience launched a brand new analysis panel centered on figuring out respiratory illnesses, together with the novel coronavirus behind the COVID-19 pandemic.
Utilizing a next-generation sequencing strategy, the panel can detect a variety of coronaviruses in addition to rhinoviruses, adenoviruses, enteroviruses, respiratory syncytial virus and completely different strains of influenza in a single pattern—29 widespread human respiratory viruses in all.
“The signs of COVID-19 are extraordinarily assorted, in lots of instances mimicking a variety of different widespread sicknesses together with influenza, adenovirus infections and even the widespread chilly,” said Twist’s co-founder and CEO, Emily Leproust, Ph.D.
“By providing a complete respiratory panel with the power to detect and characterize a variety of viruses, this assay supplies an vital device that matches inside a number of workflows to appropriately establish and analysis the underlying virus inflicting the an infection or co-infection,” Leproust stated.
Although not a medical diagnostic take a look at itself, the analysis use solely panel can be utilized to assist “surveil populations for early indicators of outbreak, viral transmission and evolution to reinforce public well being response,” she added, together with each DNA- and RNA-based viruses in a single package.
Earlier this month, Twist expanded its providing of artificial SARS-CoV-2 RNA controls used to assist develop and validate coronavirus diagnostic assessments. These embody 4 new variants of the novel coronavirus’s genetic materials, together with mutations seen in numerous geographic areas.